VANCOUVER, BC, Jan. 21, 2025 /PRNewswire/ - Human in Motion Robotics, a global leader in robotic mobility and humanoid technology, is…
PALO ALTO, Calif., Jan. 21, 2025 /PRNewswire/ -- Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma, and…
CARROLLTON, Ga., Jan. 21, 2025 /PRNewswire/ -- 121G Consulting proudly announces the approval and acceptance of its 10Bridge interoperability platform…
Proven technology powers end-to-end solution designed to streamline site activation workflows, improve engagement, and optimize visibility among trial stakeholders COLUMBIA,…
Report highlights greater visibility in AI Nose developments, including robotics, smart manufacturing, elderly care monitoring, and women's health testing SAN…
SON-1010, after receipt of data suggesting clinical benefit when administered as a monotherapy in patients with advanced solid tumors, enters…
The Companies intend to first initiate a Phase 2a clinical trial evaluating Xyngari™ with Daxxify® to treat primary axillary hyperhidrosis…
CARMEL, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology…
GAITHERSBURG, Md., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development…
- Only dual route gene transfer therapy in development to treat Friedreich’s ataxia with FDA IND clearance and Fast Track…